CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 4, 2022 · earnings

NTLA earnings: a negative outcome, -8.7%

On August 4, 2022, Intellia Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.7% in the window around the event.

The move

$71.70
1d before
$65.43
Event day
$63.32
1d after
$60.41
5d after

Pre-catalyst setup

-0.7%
30-day run-up
6932%
30-day volatility
2.3×
volume spike